Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im. Ks. B. Markiewicza
About Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im. Ks. B. Markiewicza
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Hoffmann-La Roche
9
Janssen Research & Development, LLC
8
Pfizer
8
BeiGene
4
Gilead Sciences
3
AVEO Pharmaceuticals, Inc.
2
Incyte Corporation
2
Takeda
2
Celgene
1
EMD Serono Research & Development Institute, Inc.
1
Eisai Inc.
1
Clinical Trials at Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im. Ks. B. Markiewicza
During the past decade, Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im. Ks. B. Markiewicza conducted 35 clinical trials. In the 10-year time frame, 35 clinical trials started and 24 clinical trials were completed, i.e. on
average, 68.6% percent of trials that started reached the finish line to date. In the past 5 years, 12 clinical trials started and 12 clinical trials were completed. i.e. 100%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
A Study of Bevacizumab (Avastin) in Combination With Rituximab (MabThera) and CHOP (Cyclophosphamide, Hydroxydaunorubicin [Doxorubicin], Oncovin [Vincristine], Prednisone) Chemotherapy in Patients With Diffuse Large B-cell Lymphoma
2007-07-26
2011-11-30
Terminated
787
A Study of a Combination of Trastuzumab and Capecitabine With or Without Pertuzumab in Patients With HER2-positive Metastatic Breast Cancer (PHEREXA)
2010-01-26
2017-08-07
Completed
452
A Study of Obinutuzumab in Combination With CHOP Chemotherapy Versus Rituximab With CHOP in Participants With CD20-Positive Diffuse Large B-Cell Lymphoma (GOYA)
2011-07-26
2018-01-31
Terminated
1,418
Study Evaluating the Efficacy and Safety of Idelalisib in Combination With Bendamustine and Rituximab for Previously Treated Chronic Lymphocytic Leukemia (CLL) (Tugela )
2012-06-15
2019-06-10
Completed
416
A Study to Evaluate the Safety and Efficacy of Amphinex Induced PCI of Bleomycin for Recurrent Head and Neck Cancer.
2012-04-01
2016-01-01
Terminated
26
Efficacy and Safety of Idelalisib in Combination With Ofatumumab for Previously Treated Chronic Lymphocytic Leukemia
2012-12-04
2018-08-15
Terminated
261
Safety and Efficacy of Pomalidomide, Bortezomib and Low-dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma
2013-01-07
2022-05-13
Completed
559
A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastroesophageal Junction or Gastric Cancer
2013-06-10
2019-12-31
Completed
780
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im. Ks. B. Markiewicza" #1 sponsor was "Hoffmann-La Roche" with 9 trials, followed by "Janssen Research & Development, LLC" with 8 trials
sponsored, "Pfizer" with 8 trials sponsored, "BeiGene" with 4 trials sponsored and "Gilead Sciences"
with 4 trials sponsored. Other sponsors include 13 different institutions and
companies that sponsored additional 20 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im. Ks. B. Markiewicza"
#1 collaborator was "Merck KGaA, Darmstadt, Germany" with 4 trials as a collaborator, "Eli Lilly and Company" with 3 trials as a collaborator, "Bristol-Myers Squibb" with 2 trials as a collaborator, "Merck Sharp & Dohme LLC" with 2 trials as a collaborator and "Ono Pharmaceutical Co. Ltd" with 2 trials as a collaborator. Other collaborators include 7 different institutions and companies that were
collaborators in the rest 16 trials.
Clinical Trials Conditions at Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im. Ks. B. Markiewicza
According to Clinical.Site data, the most researched conditions in "Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im. Ks. B. Markiewicza" are
"Multiple Myeloma" (6 trials), "Chronic Lymphocytic Leukemia" (5 trials), "Gastric Cancer" (4 trials), "Renal Cell Carcinoma" (4 trials) and "Small Lymphocytic Lymphoma" (3 trials). Many other conditions were trialed in "Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im. Ks. B. Markiewicza" in a lesser frequency.
Clinical Trials Intervention Types at Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im. Ks. B. Markiewicza
Most popular intervention types in "Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im. Ks. B. Markiewicza" are "Drug" (50 trials), "Other" (4 trials) and "Biological" (2 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (14 trials), "Rituximab" (7 trials), "Dexamethasone" (5 trials), "Atezolizumab" (4 trials) and "Capecitabine" (4 trials). Other intervention names were less common.
Clinical Trials Genders at Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im. Ks. B. Markiewicza
The vast majority of trials in "Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im. Ks. B. Markiewicza" are
47 trials for "All" genders, 2 trials for "Male" genders and 1 trials for "Female" genders.
Clinical Trials Status at Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im. Ks. B. Markiewicza
Currently, there are NaN active trials in "Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im. Ks. B. Markiewicza".
undefined are not yet recruiting,
11 are recruiting,
14 are Active, not recruiting,
and 1 are Enrolling by invitation.
In total, there were 15 completed trials in Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im. Ks. B. Markiewicza,
undefined suspended trials,
and 8 terminated clinical trials to date.
Out of the total trials that were conducted in Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im. Ks. B. Markiewicza, 1 "Phase 1"
clinical trials were conducted, 15 "Phase 2" clinical
trials and 37 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".
Departments of Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im. Ks. B. Markiewicza
Szpital Specjalistyczny w Brzozowie Podkarpacki Osrodek Onkologiczny im. Ks. B. Markiewicza has several departments that took part in Clinical trials: "Szpital Specjalistyczny POO im. ks. B.Markiewicza; Dzienny Oddz Chemioter i Hematologii Onkol" - 2 trials
Departments List